CD200 and cervical cancer: Furthermore, the membrane glycoprotein CD200 of the immunoglobulin superfamily, and its soluble formulation CD200 fusion protein Fc (CD200Fc), has been demonstrated to play an active role in the suppression of the inflammatory activity of the TLR4-NF-kappaB and NLRP3 inflammasome pathways in LPS-induced cervical cancer cell lines [130].